JMP Securities reiterated their market perform rating on shares of Cross Country Healthcare (NASDAQ:CCRN - Free Report) in a research report released on Thursday,Benzinga reports.
A number of other equities research analysts have also recently commented on CCRN. Truist Financial raised their price target on Cross Country Healthcare from $15.00 to $18.61 and gave the company a "hold" rating in a report on Thursday, December 5th. Barrington Research reissued a "market perform" rating on shares of Cross Country Healthcare in a report on Tuesday, December 10th. Benchmark cut shares of Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, December 4th. William Blair downgraded shares of Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a report on Wednesday, December 4th. Finally, StockNews.com initiated coverage on shares of Cross Country Healthcare in a research note on Friday, January 31st. They set a "hold" rating for the company. Six investment analysts have rated the stock with a hold rating, Based on data from MarketBeat, Cross Country Healthcare currently has a consensus rating of "Hold" and an average price target of $18.54.
Get Our Latest Research Report on CCRN
Cross Country Healthcare Stock Up 0.1 %
NASDAQ:CCRN traded up $0.02 during trading hours on Thursday, hitting $18.20. 252,461 shares of the stock traded hands, compared to its average volume of 436,212. The stock has a 50 day moving average price of $17.85 and a 200 day moving average price of $14.90. The company has a market cap of $597.32 million, a price-to-earnings ratio of -363.93, a price-to-earnings-growth ratio of 3.35 and a beta of 0.44. Cross Country Healthcare has a 1 year low of $9.58 and a 1 year high of $21.41.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of CCRN. Truvestments Capital LLC bought a new position in Cross Country Healthcare during the third quarter valued at $39,000. Plato Investment Management Ltd bought a new position in shares of Cross Country Healthcare in the 4th quarter valued at about $46,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in Cross Country Healthcare in the third quarter worth about $49,000. Point72 DIFC Ltd bought a new stake in Cross Country Healthcare during the third quarter worth approximately $52,000. Finally, Gladius Capital Management LP raised its position in Cross Country Healthcare by 83.4% during the third quarter. Gladius Capital Management LP now owns 3,985 shares of the business services provider's stock valued at $54,000 after purchasing an additional 1,812 shares during the period. 96.03% of the stock is owned by hedge funds and other institutional investors.
Cross Country Healthcare Company Profile
(
Get Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Read More

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.